IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine-Reference-Cited by-同舟云学术

IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

Published:2012-10-17 Issue:7423 Volume:491 Page:259-263
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Huber Samuel,Gagliani Nicola,Zenewicz Lauren A.,Huber Francis J.,Bosurgi Lidia,Hu Bo,Hedl Matija,Zhang Wei,O’Connor William,Murphy Andrew J.,Valenzuela David M.,Yancopoulos George D.,Booth Carmen J.,Cho Judy H.,Ouyang Wenjun,Abraham Clara,Flavell Richard A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11535.pdf

Reference35 articles.

1. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010)

2. Brand, S. et al. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G827–G838 (2006)

3. Wolk, K. et al. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn’s disease. J. Immunol. 178, 5973–5981 (2007)

4. Witte, E., Witte, K., Warszawska, K., Sabat, R. & Wolk, K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 21, 365–379 (2010)

5. Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nature Immunol. 12, 383–390 (2011)

Cited by 627 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

2. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10

3. The role of IL-22 in cancer;Medical Oncology;2024-09-05

4. IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer;Heliyon;2024-09

5. Inverse correlation between NLRP3 and TMEM176B as a possible tool for colorectal cancer progression;2024-08-31